Incidence and Relative Risk of COVID-19 in Adolescents and Youth Compared With Older Adults in 19 US States, Fall 20202020년 가을 미국 19개 주에서 노인과 비교한 청소년 및 청소년의 COVID-19 발병률 및 상대적 위험Article Published on 2022-07-012022-09-11 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI Adolescent Adults age analyzed Asia contrary COVID COVID-19 COVID-19 infection cross-sectional cross-sectional study delta variant dependent on Europe example exceeded greater group health department incidence incidence rate incidence rates individual Infection Lineage Older outcome pandemic participant rate ratio relative Relative risk reported Result risk risk of COVID-19 risk of infection significantly state health department susceptibility thought threshold website wild-type wild-type SARS-CoV-2 wild-type strain Youth [DOI] 10.1001/jamanetworkopen.2022.22126 PMC 바로가기 [Article Type] Article
Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic임상 실습의 최근 발전: COVID-19 대유행 중 염증성 장 질환 관리Review Published on 2022-07-012022-09-11 Journal: Gut [Category] COVID19(2023년), SARS, 치료기술, [키워드] acquisition adverse outcome adverse outcomes antibody booster dose bowel Breakthrough infection breakthrough infections Cancer cancers Corticosteroid Corticosteroids COVID-19 COVID-19 in patient COVID-19 pandemic Crohn's disease de novo decrease develop diagnoses disease course dose Evidence Future General population Guidance hospitalisation hospitalisations Humoral response humoral responses IBD immune immune response immunosuppressive therapies immunosuppressive therapy increased risk Inflammatory Inflammatory bowel disease management medication medications Necrosis outcome outcomes pandemic Patient patients potential risk primary dose raised receive recent remained Research risk risk of COVID-19 SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 vaccines TNF treated Treatment ulcerative ulcerative colitis Vaccine vaccine response Vaccines [DOI] 10.1136/gutjnl-2021-326784 PMC 바로가기 [Article Type] Review
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design스코틀랜드의 증후성 질환에 대한 백신 부스터의 우려 및 효과에 대한 오미크론 변이의 심각도(EAVE II): 중첩 테스트 음성 디자인을 사용한 국가 코호트 연구Article Published on 2022-07-012022-09-11 Journal: The Lancet. Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted Admission booster booster dose Booster vaccine booster vaccines Care case-control study cohort analysis cohort study core COVID-19 defined Delta VOC dose dose of vaccination Edinburgh effective Effectiveness enhanced estimate Health Data Research UK Hospital admission hospitalisation individual individuals Infection initial Innovation laboratory data National offer omicron Omicron variant outcome platform positive positive RT-PCR proportion Public reduction in Reinfection risk risk of COVID-19 S-gene SARS-COV-2 infection Scottish severity Spread symptomatic symptomatic COVID-19 symptomatic disease symptomatic infection symptomatic SARS-CoV-2 infection tested the SARS-CoV-2 university vaccination Vaccine vaccine dose VoC with infection [DOI] 10.1016/S1473-3099(22)00141-4 PMC 바로가기 [Article Type] Article
Cross-sectional survey of changes in knowledge, attitudes and practice of mask use in Sydney and Melbourne during the 2020 COVID-19 pandemicObservational Study Published on 2022-06-222022-10-04 Journal: BMJ Open [Category] COVID19(2023년), SARS, 임상, [키워드] 2020 COVID-19 pandemic 95% CI changes in Cluster Compliance COVID-19 COVID-19 infection COVID-19 pandemic COVID-19 severity cross-sectional survey decrease Epidemiology explained Government Infection information knowledge mask mandate Mask mandates Measures Melbourne Melbourne, Australia National no significant difference Older outbreak pandemic participant Perceived Personal protective equipment public health reported risk risk of COVID-19 risk perceptions second wave secondary outcome setting severity significantly susceptibility the timing timepoint Trust Victoria [DOI] 10.1136/bmjopen-2021-057860 PMC 바로가기 [Article Type] Observational Study
Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium벨기에에서 수집된 국가 감시 데이터 분석을 통한 코로나19 백신이 입원 위험에 미치는 영향 조사Article Published on 2022-06-162022-09-11 Journal: Viruses [Category] COVID19(2023년), SARS, 변종, [키워드] absence Administered age analysed Belgium booster vaccination category Comorbidities COVID-19 COVID-19 hospitalisation COVID-19 patient dominance Evolution Factor hospitalisation hospitalisation surveillance hospitalised Impact infections National omicron Omicron variant Probability receive risk risk of COVID-19 risk ratio risk ratios SARS-CoV-2 SARS-COV-2 infection stratified surveillance data vaccination Vaccination impact Vaccination Status Vaccine variant waning immunity [DOI] 10.3390/v14061315 PMC 바로가기 [Article Type] Article
Experimental pre-tests of public health communications on the COVID-19 vaccine: A null finding for medical endorsement, risk and altruismRandomized Controlled Trial Published on 2022-06-152022-10-05 Journal: Vaccine [Category] COVID19(2023년), SARS, 임상, [키워드] assigned Behavioural Science benefit communication Control COVID-19 COVID-19 vaccine effective eight Government Guidance Health policy hospital information Intention Intervention less no effect outcome participant positive Poster PROTECT Public public health public health communication randomised controlled trial Randomly reaction Research risk risk of COVID-19 Risk perception tested the vaccine vaccination Vaccine hesitancy Vaccine Intention. [DOI] 10.1016/j.vaccine.2022.05.029 PMC 바로가기 [Article Type] Randomized Controlled Trial
Severity and mortality of COVID-19 among people with disabilities: protocol for a systematic review and meta-analysis장애가있는 사람들의 Covid-19의 심각성 및 사망률 : 체계적인 검토 및 메타 분석을위한 프로토콜Article Published on 2022-06-142022-08-31 Journal: BMJ Open [Category] COVID19(2023년), MERS, meta-analysis, SARS, [키워드] 95% CI analysed Case-control Cochrane Library Cohort conducted COVID-19 COVID-19 infection COVID-19 pandemic Cross-sectional studies cross-sectional study determine English language Ethical approval Ethics Final global healthcare Google Scholar greater Grey literature Health heterogeneity HINARI Hospital stay hospitalisation include Infection Informed consent International medRxiv Meta-analysis Mortality National Newcastle-Ottawa Scale outcome PROSPERO protocol Public public health registration number required review risk risk of bia Risk of bias risk of COVID-19 severity statistical analysis subsequent systematic review used to calculate variable variables [DOI] 10.1136/bmjopen-2022-061438 PMC 바로가기 [Article Type] Article
A measure to estimate the risk of imported COVID-19 cases and its application for evaluating travel-related control measures Research Published on 2022-06-092022-10-05 Journal: Scientific Reports [Category] 치료기술, [키워드] applied calculated Community COVID-19 COVID-19 case COVID-19 testing COVID-19 transmission develop Diseases effective Effectiveness Evidence expected facilitate identify Local measure Measures predicted Prevalence quarantine risk risk of COVID-19 Spread Volume [DOI] 10.1038/s41598-022-13775-0 [Article Type] Research
Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID-19 cohorts by chemiluminescent immunoassays화학발광 면역분석에 의한 백신 접종 및 회복기 COVID-19 코호트에서 중화 및 결합 항체의 종단 프로필Article Published on 2022-06-012022-09-11 Journal: Immunity, Inflammation and Disease [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] antibodies antibody antibody profile, COVID-19 convalescent Antibody testing binding antibody booster vaccination chemiluminescent immunoassay coefficient coefficient of correlation convalescent correlation COVID-19 COVID-19 cohort diagnostic dose elicited enrolled enzyme evaluate evaluated exhibited extension humoral immune response Humoral immunity IgG Immune status Immunity immunoassay Immunoglobulin Immunoglobulin G inactive Infection Interpretation longitudinal Neutralizing neutralizing antibody no difference priming priming dose Protective RBD RBD IgG referred to risk of COVID-19 SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 neutralizing antibody SARS-CoV-2 RBD SARS-CoV-2 vaccine seroconversion rate serological Serological assay serum surrogate the SARS-CoV-2 therapy threshold trajectory vaccination vaccination schedule Vaccine Volunteer was collected [DOI] 10.1002/iid3.612 PMC 바로가기 [Article Type] Article
SARS-CoV-2 IgG Amongst Dental Workers During the COVID-19 PandemicCOVID-19 전염병 동안 치과 종사자들 사이에서 SARS-CoV-2 IgGArticle Published on 2022-06-012022-09-11 Journal: International dental journal [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] aerosol aerosol-generating procedure aerosol-generating procedures Analysis Asymptomatic contracting the virus COVID-19 COVID-19 transmission cycle dental dental clinic dental hygienists dentist dentistry dentists determine diagnostic Efficacy ELISA enzyme-linked immunosorbent enzyme-linked immunosorbent assay evaluate Health IgG IgG levels Immunoglobulin Immunoglobulin G in vitro introduced Laboratory Laboratory test Laboratory tests Neutralising Antibodies neutralising antibody Nurses outbreak pandemic participant Pearson Prevalence professional protocol provided Quantitative questionnaire Questionnaires Research risk risk of COVID-19 SARS-CoV-2 SARS-CoV-2 IgG semi-quantitative Seropositivity serum serum IgG study group Study protocol SUB1 the SARS-CoV-2 Transmission were measured worker [DOI] 10.1016/j.identj.2022.02.003 PMC 바로가기 [Article Type] Article